These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 28566441)

  • 1. Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies.
    Luo X; Hou L; Liang L; Dong G; Shen S; Zhao Z; Gong CX; Li Y; Du ML; Su Z; Du H; Yan C
    Eur J Endocrinol; 2017 Aug; 177(2):195-205. PubMed ID: 28566441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children.
    Hou L; Chen ZH; Liu D; Cheng YG; Luo XP
    Drug Des Devel Ther; 2016; 10():13-21. PubMed ID: 26719670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Effectiveness and Comparable Safety in Biweekly
    Sun C; Lu B; Liu Y; Zhang Y; Wei H; Hu X; Hu P; Zhao Q; Liu Y; Ye K; Wang K; Gu Z; Liu Z; Ye J; Zhang H; Zhu H; Jiang Z; Liu Y; Wan N; Yan C; Yin J; Ying L; Huang F; Yin Q; Xi L; Luo F; Cheng R
    Front Endocrinol (Lausanne); 2021; 12():779365. PubMed ID: 34899612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEGylated Recombinant Human Growth Hormone Jintrolong
    Wu W; Zhou J; Wu C; Zhou Q; Li X; Zhang Y; Zuo C; Yin J; Hou L; Wang S; Gao H; Luo T; Jin L; Zhong E; Wang Y; Luo X
    Front Endocrinol (Lausanne); 2022; 13():821588. PubMed ID: 35909512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of efficacy and safety of long-acting PEGylated recombinant human growth hormone (Jintrolong) for patients with growth hormone deficiency.
    Du H; Wu D; Yi P; Bai X; Luo Y; Yang H; Chen S; Pan H; Zhu H
    J Pediatr Endocrinol Metab; 2022 Apr; 35(4):511-517. PubMed ID: 35245011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of long-acting PEGylated growth hormone for catch-up growth in children with idiopathic short stature: a 2-year real-world retrospective cohort study.
    Xie L; Li Y; Zhang J; Guo S; Chen Q; Ma H; Jiang W
    Eur J Pediatr; 2024 Oct; 183(10):4531-4539. PubMed ID: 39158594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-acting pegylated recombinant human growth hormone (Jintrolong
    Guan Y; He F; Wu J; Zhao L; Wang X; Huang L; Zeng G; Ren B; Chen J; Liao X; Ma Z; Chen X; Zhong G; Huang M; Zhao X
    J Clin Pharm Ther; 2018 Oct; 43(5):640-646. PubMed ID: 29959799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy and safety of PEGylated recombinant human growth hormone in treating Chinese children with growth hormone deficiency: a 5-year retrospective study.
    Hou L; Lin S; Liu Z; Zhang L; Ou H; Huang S; Dai H; Meng Z; Liang L
    J Pediatr Endocrinol Metab; 2024 Oct; 37(10):892-899. PubMed ID: 39190198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetic and pharmacodynamic properties and short-term outcome of a novel once-weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency.
    Liang Y; Zhang C; Wei H; Du H; Zhang G; Yang Y; Zhang H; Gong H; Li P; Song F; Xu Z; He R; Zhou W; Zheng H; Sun L; Luo X
    Front Endocrinol (Lausanne); 2022; 13():922304. PubMed ID: 36034448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic/pharmacodynamic analysis of PEG-rhGH enhances confidence in exploring dosing schemes with longer intervals.
    Cheng R; Zhao Q; Zhong G; Xu J; Zheng Z; Xi L; Zhang M; Ni J; Hu P; Luo F; Lu W
    Eur J Pharm Sci; 2022 Dec; 179():106304. PubMed ID: 36209987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Pegylated GH for Children With GH Deficiency: A Large, Prospective, Real-world Study.
    Hou L; Huang K; Gong C; Luo F; Wei H; Liang L; Du H; Zhang J; Zhong Y; Chen R; Chen X; Pan J; Jin X; Zeng T; Liao W; Liu D; Lan D; Zhu S; Dong Z; Ma H; Yang Y; Xiong F; Lu P; Cheng S; Gu X; Jin R; Liu Y; Wu J; Xu X; Chen L; Dong Q; Pan H; Su Z; Liu L; Luo X; Ni S; Chen Z; Hu Y; Wang C; Liu J; Liu L; Lu B; Wang X; Wang Y; Yang F; Zhang M; Cao L; Liu G; Yao H; Zhan Y; Dai M; Li G; Li L; Liu Y; Wang K; Xiao Y; Zhang X; Dong J; Gu Z; Ying L; Huang F; Liu Y; Liu Z; Ye J; Zhao D; Hu X; Jiang Z; Ye K; Zhu H; Chen S; Chen X; Wan N; Xu Z; Yin Q; Zhang H; Huang X; Yin J; Zhang H; Li P; Yin P; Fu J; Luo X
    J Clin Endocrinol Metab; 2023 Jul; 108(8):2078-2086. PubMed ID: 36669772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term efficacy and safety of a lower dose of polyethylene glycol recombinant human growth hormone in children with growth hormone deficiency: A randomized, dose-comparison study.
    Jiang Z; Chen X; Dong G; Lou Y; Zhang J; Cheng X; Pan J; Liao W; Wu J; Huang X; Jin X; Liu D; Zeng T; Zhu S; Dong Q; Luo X; Lan D; Cao L; Zhang X; Liu J; Dai M; Zhang M; Liu L; Dong J; Zhao D; Ni S; Fu J
    Front Pharmacol; 2022; 13():955809. PubMed ID: 36034802
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study.
    Deal CL; Steelman J; Vlachopapadopoulou E; Stawerska R; Silverman LA; Phillip M; Kim HS; Ko C; Malievskiy O; Cara JF; Roland CL; Taylor CT; Valluri SR; Wajnrajch MP; Pastrak A; Miller BS
    J Clin Endocrinol Metab; 2022 Jun; 107(7):e2717-e2728. PubMed ID: 35405011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.
    Hou L; Liang Y; Wu W; Lin HH; Luo XP; Ying YQ
    Growth Horm IGF Res; 2020; 53-54():101331. PubMed ID: 32777706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-Weekly Administration of Sustained-Release Growth Hormone in Korean Prepubertal Children with Idiopathic Short Stature: A Randomized, Controlled Phase II Study.
    Hwang JS; Lee HS; Lee KH; Yoo HW; Lee DY; Suh BK; Ko CW; Chung WY; Jin DK; Shin CH; Han HS; Han S; Kim HS
    Horm Res Paediatr; 2018; 90(1):54-63. PubMed ID: 29925064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial.
    Sävendahl L; Battelino T; Brod M; Højby Rasmussen M; Horikawa R; Juul RV; Saenger P;
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1847-61. PubMed ID: 31917835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency.
    Hwang JS; Lee HS; Chung WY; Han HS; Jin DK; Kim HS; Ko CW; Lee BC; Lee DY; Lee KH; Shin JH; Suh BK; Yoo HW; Ji HJ; Lee JH; Bae YJ; Kim DH; Yang SW
    Eur J Endocrinol; 2013 Aug; 169(2):179-85. PubMed ID: 23682096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Phase 2 Study of Long-Acting TransCon GH vs Daily GH in Childhood GH Deficiency.
    Chatelain P; Malievskiy O; Radziuk K; Senatorova G; Abdou MO; Vlachopapadopoulou E; Skorodok Y; Peterkova V; Leff JA; Beckert M;
    J Clin Endocrinol Metab; 2017 May; 102(5):1673-1682. PubMed ID: 28201598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of growth hormone deficiency in children, adolescents and at the transitional age.
    Richmond E; Rogol AD
    Best Pract Res Clin Endocrinol Metab; 2016 Dec; 30(6):749-755. PubMed ID: 27974188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.